Scientific Publications

This page contains links to articles written by persons not affiliated with Cabaletta. These third-party articles are identified for background and historical purposes only, and Cabaletta does not purport that they represent a complete survey of the relevant science. The views expressed in the articles are those of the respective authors and do not reflect the views of Cabaletta. Cabaletta has not independently verified any of the information contained in the third-party articles and disavows any obligation to update or correct the information contained in these articles.

Science: Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease; Christoph T. Ellebrecht, Vijay G. Bhoj, Arben Nace, Eun Jung Choi, Xuming Mao, Michael Jeffrey Cho,Giovanni Di Zenzo, Antonio Lanzavecchia, John T. Seykora, George Cotsarelis, Michael C. Milone, Aimee S. Payne

Publication Link

Science: Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus; Spindler V1, Eming R2, Schmidt E3, Amagai M4, Grando S5, Jonkman MF6, Kowalczyk AP7, Müller EJ8, Payne AS9, Pincelli C10, Sinha AA11, Sprecher E12, Zillikens D13, Hertl M2, Waschke J14.

Publication Link

Cellular Immunotherapy for Immune Disease: Cell & Gene Therapy Insights; Advances in Targeting CAR-T Therapy for Immune-Mediated Diseases; Lee J, Payne AS

Publication Link

Pemphigus: Journal of Investigative Dermatology; Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus; Spindler V, Eming R, Schmidt E, Amagai M, Grando S, Jonkman MF, Kowalczyk AP, Muller EJ, Payne AS, Pincelli C, Sinha AA, Sprecher E, Zillikens D, Hertl M, Waschke J

Publication Link

Pemphigus: Nature Reviews Disease Primers; Kasperkiewicz M, Ellebrecht CT, Takahashi H, Yamagami J, Zillikens D, Payne AS, Amagai M.

Publication Link

Pemphigus: Lancet; First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial; Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C.

Publication Link

Pemphigus: JCI Insight; Setting the target for pemphigus vulgaris therapy; Ellebrecht CT, Payne AS.

Publication Link

Pemphigus: Science; Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease; Ellebrecht CT, Bhoj VG, Nace A, Choi EJ, Mao X, Cho MJ, Di Zenzo G, Lanzavecchia A, Seykora JT, Cotsarelis G, Milone MC, Payne AS.

Publication Link

Pemphigus: Journal of Investigative Dermatology; Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years; Hammers CM, Chen J, Lin C, Kacir S, Siegel DL, Payne AS, Stanley JR

Publication Link

Pemphigus: Journal of Investigative Dermatology; Epitope Spreading Is Rarely Found in Pemphigus Vulgaris by Large-Scale Longitudinal Study Using Desmoglein 2–Based Swapped Molecules; Ohyama B, Nishifuji K, Chan PT, Kawaguchi A, Yamashita T, Ishii N, Hamada T, Dainichi T, Koga H, Tsuruta D, Amagai M

Publication Link

Manufacturing and Legacy CAR T Cell Products: Leukemia; Clinical use of lentiviral vectors; Milone MC, O'Doherty U

Publication Link

Manufacturing and Legacy CAR T Cell Products: Cancer Immunology Research; Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells; Ghassemi S, Nunez-Cruz S, O'Connor RS, Fraietta JA, Patel PR, Scholler J, Barrett DM, Lundh SM, Davis MM, Bedoya F, Zhang C, Leferovich J, Lacey SF, Levine BL, Grupp SA, June CH, Melenhourst JJ, Milone MC.

Publication Link

Manufacturing and Legacy CAR T Cell Products: Blood; False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy; Theodore W. Laetsch, Shannon L. Maude, Michael C. Milone, Kara L. Davis, Joerg Krueger, Ana Maria Cardenas, Lamis K. Eldjerou, Christopher H. Keir, Patricia A. Wood and Stephan A. Grupp.

Publication Link

Manufacturing and Legacy CAR T Cell Products: Science; CAR T cell immunotherapy for human cancer; Carl H. June, Roddy S. O’Connor, Omkar U. Kawalekar, Saba Ghassemi, Michael C. Milone.

Publication Link

Manufacturing and Legacy CAR T Cell Products: Molecular Therapy; The Pharmacology of T Cell Therapies; Michael C. Milone, Vijay G. Bhoj;

Publication Link

Manufacturing and Legacy CAR T Cell Products: Molecular Therapy; Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo; Milone MC, Fish JD, Carpenito C, Carroll RG, Binder GK, Teachey D, Samanta M, Lakhal M, Gloss B, Danet-Desnoyers G, Campana D

Publication Link